értekezés - Semmelweis Egyetem Doktori Iskola
értekezés - Semmelweis Egyetem Doktori Iskola értekezés - Semmelweis Egyetem Doktori Iskola
126. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990; 16: 301-7. 127. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 1994; 93: 1911-21. 128. Protter AA, Wallace AM, Ferraris VA, Weishaar RE. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 1996; 9: 432-6. 129. van der Zander K, Houben AJ, Kroon AA, de Leeuw PW. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide. Cardiovasc Res 1999; 44: 595-600. 130. Nakamura M, Arakawa N, Yoshida H, Makita S, Niinuma H, Hiramori K. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J 1998; 135: 414-20. 131. Tonolo G, Richards AM, Manunta P, Troffa C, Pazzola A, Madeddu P, Towrie A, Fraser R, Glorioso N. Low-dose infusion of atrial natriuretic factor in mild essential hypertension. Circulation 1989; 80: 893-902. 132. Richards AM, McDonald D, Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H, Jans S, Grant S, Yandle T. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134-9. 133. Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 2005; 19: 411-9. 134. Lazzeri C, La Villa G, Bisi G, Boddi V, Messeri G, Strazzulla G, Franchi F. Cardiovascular function during brain natriuretic peptide infusion in man. Cardiology 1995; 86: 396-401. 135. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Hemodynamic, renal, and hormonal 100
esponses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-8. 136. Yasue H, Yoshimura M. Natriuretic peptides in the treatment of heart failure. J Card Fail 1996; 2(4 Suppl): S277-85. 137. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med 1989; 87: 24S-28S. 138. Shi SJ, Nguyen HT, Sharma GD, Navar LG, Pandey KN. Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol Renal Physiol 2001; 281: F665-73. 139. Richards AM, Tonolo G, Tree M, Robertson JI, Montorsi P, Leckie BJ, Polonia J. Atrial natriuretic peptides and renin release. Am J Med 1988; 84: 112-8. 140. De Léan A, Racz K, Gutkowska J, Nguyen TT, Cantin M, Genest J. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone- stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology 1984; 115: 1636-8. 141. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H, Ogawa H. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 2003; 107: 807-10. 142. Leskinen H, Vuolteenaho O, Tóth M, Ruskoaho H. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Endocrinology 1997; 138: 1893-902. 143. Sigurdsson A, Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J 1996; 132: 229-34. 144. Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. Clin Sci (Lond) 2004; 106: 569-76. 145. Luchner A, Schunkert H. Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc Res 2004; 63: 443-9. 101
- Page 49 and 50: 4.4. A nátriuretikus peptidek szin
- Page 51 and 52: Az alcsoport vizsgálatban (II. pop
- Page 53 and 54: ln NT-proXNP (pmol/l) 10,0 8,0 6,0
- Page 55 and 56: 4.6. A hemodinamikai paraméterek j
- Page 57 and 58: A műtét után egy nappal az SVI
- Page 59 and 60: 4.6.5. A hemodinamikai paraméterek
- Page 61 and 62: delta CI (l/min/m2) 8.0 4.0 0.0 -4.
- Page 63 and 64: 4.7.2. A klinikai paraméterek öss
- Page 65 and 66: 4.9. A nátriuretikus peptidek diag
- Page 67 and 68: 5. Megbeszélés Egy 10 év adatait
- Page 69 and 70: verőtérfogat műtét utáni vált
- Page 71 and 72: lélegeztetve. A felnőttekben elfo
- Page 73 and 74: mediátorok felszabadulását okozz
- Page 75 and 76: mind az NT-proBNP molekulából tar
- Page 77 and 78: 5.4. A nátriuretikus peptidek és
- Page 79 and 80: magasabb NT-proANP szintek és a na
- Page 81 and 82: emelkedése megelőzi a vesefunkci
- Page 83 and 84: kockázatokkal járhat a betegekre
- Page 85 and 86: 5. A szívindex referencia értéke
- Page 87 and 88: Summary Natriuretic peptide levels
- Page 89 and 90: 12. Sudoh T, Minamino N, Kangawa K,
- Page 91 and 92: 33. Murakami Y, Shimada T, Inoue S,
- Page 93 and 94: 54. Lang RE, Thölken H, Ganten D,
- Page 95 and 96: 75. Fukuda Y, Hirata Y, Taketani S,
- Page 97 and 98: 95. Yoshimoto T, Naruse M, Tanabe A
- Page 99: 116. Tei M, Horie M, Makita T, Suzu
- Page 103 and 104: paracrine factor in cultured cardia
- Page 105 and 106: 174. Matsuoka S, Kurahashi Y, Tomim
- Page 107 and 108: 191. Lan YT, Chang RK, Alejos JC, B
- Page 109 and 110: 213. Egan JR, Festa M, Cole AD, Nun
- Page 111 and 112: 234. Lehot JJ, Villard J, Piriz H,
- Page 113 and 114: 4. Székely A, Sápi E, Breuer T, K
esponses to brain natriuretic peptide infusion in patients with congestive heart<br />
failure. Circulation 1991; 84: 1581-8.<br />
136. Yasue H, Yoshimura M. Natriuretic peptides in the treatment of heart failure. J<br />
Card Fail 1996; 2(4 Suppl): S277-85.<br />
137. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA.<br />
Interaction between atrial natriuretic peptide and the renin angiotensin<br />
aldosterone system. Endogenous antagonists. Am J Med 1989; 87: 24S-28S.<br />
138. Shi SJ, Nguyen HT, Sharma GD, Navar LG, Pandey KN. Genetic disruption of<br />
atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J<br />
Physiol Renal Physiol 2001; 281: F665-73.<br />
139. Richards AM, Tonolo G, Tree M, Robertson JI, Montorsi P, Leckie BJ, Polonia<br />
J. Atrial natriuretic peptides and renin release. Am J Med 1988; 84: 112-8.<br />
140. De Léan A, Racz K, Gutkowska J, Nguyen TT, Cantin M, Genest J. Specific<br />
receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-<br />
stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology<br />
1984; 115: 1636-8.<br />
141. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E,<br />
Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H,<br />
Ogawa H. Inhibitory effect of natriuretic peptides on aldosterone synthase gene<br />
expression in cultured neonatal rat cardiocytes. Circulation 2003; 107: 807-10.<br />
142. Leskinen H, Vuolteenaho O, Tóth M, Ruskoaho H. Atrial natriuretic peptide<br />
(ANP) inhibits its own secretion via ANP(A) receptors: altered effect in<br />
experimental hypertension. Endocrinology 1997; 138: 1893-902.<br />
143. Sigurdsson A, Swedberg K. The role of neurohormonal activation in chronic<br />
heart failure and postmyocardial infarction. Am Heart J 1996; 132: 229-34.<br />
144. Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards<br />
AM. Combined inhibition of angiotensin II and endothelin suppresses the brain<br />
natriuretic peptide response to developing heart failure. Clin Sci (Lond) 2004;<br />
106: 569-76.<br />
145. Luchner A, Schunkert H. Interactions between the sympathetic nervous system<br />
and the cardiac natriuretic peptide system. Cardiovasc Res 2004; 63: 443-9.<br />
101
Change language